
DigiTx Partners is a venture capital firm launched in 2016 as a joint venture between Astellas Pharma and MPM Capital, investing in early-stage digital health companies leveraging data-driven technology to improve patient outcomes. The firm raised $75 million for its Rx Digital Fund in 2018.
46% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deal in the last 12 months vs 2 prior). Average disclosed round size is $28.5M (across 26 rounds with reported amounts).
Portfolio
19
Fund Size
$75M
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
26 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Seed | $7.8M | Dec 2025 | |
| Unknown | $6M | Jan 2025 | |
| Series A | $10M | Dec 2024 | |
| Series C | $106M | Dec 2024 | |
| Series C | $41M | Jun 2024 | |
| Unknown | $12M | Jan 2024 | |
| Series A | $10M | Jan 2024 | |
| Series C | $125M | Jan 2024 | |
| Series C | $125M | Jan 2024 | |
| Series C | $106M | Jan 2022 | |
| Series B | $17M | Dec 2021 | |
| Series A | $12M | Sep 2021 | |
| CCleerly Coronary | Series B | $43M | Jun 2021 |
| Series A | $6.7M | Jun 2020 | |
| Series A | $6.7M | Jan 2020 | |
| Series B | $20M | Sep 2019 | |
| Series A | $10M | Jan 2019 | |
| Series A | $5M | Jan 2018 | |
| SSavonix | Seed | $1.5M | Dec 2015 |
| Series B | $35M | — | |
| Series A | $10M | — | |
| Unknown | $4M | — | |
| Seed | $1.9M | — | |
| SSavonix | Series A | $9.6M | — |
| Seed | $5M | — |
Page 1 of 2
Top Co-Investors
NTTVC4 shared
New Leaf Venture Partners3 shared
LRVHealth3 shared
The Cigna Group Ventures3 shared
Vensana Capital3 shared
Moment Ventures3 shared
TruVenturo3 shared
Village Global3 shared
Morningside3 shared
PBJ Capital2 shared
Deepwater Asset Management2 shared
Eclipse2 shared
NTT2 shared
3M Ventures2 shared
AARP2 shared
Mirae Asset2 shared
T. Rowe Price2 shared
Battery Ventures2 shared
Sands Capital2 shared
Last updated: 20 October 2026